{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T04:13:20Z","timestamp":1770524000201,"version":"3.49.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.ajem.2020.03.051","type":"journal-article","created":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T02:04:55Z","timestamp":1585620295000},"page":"1541.e3-1541.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["High-dose adenosine for treatment of refractory paroxysmal supraventricular tachycardia"],"prefix":"10.1016","volume":"38","author":[{"given":"Lily","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wesley","family":"Eilbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ajem.2020.03.051_bb0005","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pedhc.2007.08.013","article-title":"Supraventricular tachycardia in the primary care setting: age-related presentation, diagnosis, and management","volume":"22","author":"Schlechte","year":"2008","journal-title":"J Pediatr Health Care"},{"issue":"13","key":"10.1016\/j.ajem.2020.03.051_bb0010","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.jacc.2015.08.856","article-title":"2015 ACC\/AHA\/HRS guideline for the management of adult patients with supraventricular tachycardia","volume":"67","author":"Page","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ajem.2020.03.051_bb0015","first-page":"e1262","article-title":"Pediatric basic and advanced life support: 2010 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations","volume":"126","author":"Kleinman","year":"2010","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.ajem.2020.03.051_bb0020","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ajem.2007.11.029","article-title":"Adenosine in the treatment of supraventricular tachycardia: 5\u00a0years of experience (2002\u20132006)","volume":"26","author":"Riccardi","year":"2008","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.ajem.2020.03.051_bb0025","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005154.pub2","article-title":"Adenosine versus intravenous calcium channel antagonists for the treatment of supraventricular tachycardia in adults","volume":"4","author":"Holdgate","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"15","key":"10.1016\/j.ajem.2020.03.051_bb0030","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1056\/NEJMcp1111259","article-title":"Clinical practice. Evaluation and initial treatment of supraventricular tachycardia","volume":"367","author":"Link","year":"2012","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ajem.2020.03.051_bb0035","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0022-3565(25)20409-8","article-title":"Caffeine and theophylline as adenosine receptor antagonists and humans","volume":"258","author":"Biaggioni","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.ajem.2020.03.051_bb0040","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1553-2712.2009.00616.x","article-title":"Recent caffeine ingestion reduced adenosine efficacy in the treatment of paroxysmal supraventricular tachycardia","volume":"17","author":"Cabalag","year":"2010","journal-title":"Acad Emerg Med"},{"issue":"1\u20132","key":"10.1016\/j.ajem.2020.03.051_bb0045","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0014-2999(83)90026-2","article-title":"Dipyridamole inhibition of adenosine metabolism and human blood","volume":"93","author":"Klabunde","year":"1983","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.ajem.2020.03.051_bb0050","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2125.1986.tb05180.x","article-title":"Intravenous adenosine in the treatment of supraventricular tachycardia: a dose-ranging study and interaction with dipyridamole","volume":"21","author":"Watt","year":"1986","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.ajem.2020.03.051_bb0055","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/0002-8703(92)90807-8","article-title":"Adenosine versus verapamil in the treatment of supraventricular tachycardia: a randomized double-crossover study","volume":"123","author":"Hood","year":"1992","journal-title":"Am Heart J"},{"issue":"5","key":"10.1016\/j.ajem.2020.03.051_bb0060","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/oxfordjournals.eurheartj.a060553","article-title":"Adenosine for management of patients with tachycardias \u2014 a new protocol","volume":"15","author":"Domanovits","year":"1994","journal-title":"Eur Heart J"},{"issue":"33","key":"10.1016\/j.ajem.2020.03.051_bb0065","first-page":"961","article-title":"Terminating supraventricular tachycardia with adenosine \u2014 comparing the effectiveness of 12\u00a0mg and 18\u00a0mg","volume":"125","author":"Weismuller","year":"2000","journal-title":"Dtsch Med Wochenschr"},{"issue":"6","key":"10.1016\/j.ajem.2020.03.051_bb0070","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/PEC.0000000000000144","article-title":"Use of adenosine in the treatment of supraventricular tachycardia in a pediatric emergency department","volume":"30","author":"Diaz-Parra","year":"2014","journal-title":"Pediatr Emerg Care"},{"issue":"5","key":"10.1016\/j.ajem.2020.03.051_bb0075","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1017\/S1047951116002626","article-title":"High-dose adenosine for refractory supraventricular tachycardia: a case report and literature review","volume":"27","author":"Dadi","year":"2017","journal-title":"Cardiol Young"},{"issue":"3","key":"10.1016\/j.ajem.2020.03.051_bb0080","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jemermed.2015.11.012","article-title":"High-dose adenosine for treatment of refractory supraventricular tachycardia in an emergency department of an academic center: a case report and literature review","volume":"50","author":"Bailey","year":"2016","journal-title":"J Emerg Med"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675720301935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675720301935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T15:50:46Z","timestamp":1760025046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675720301935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0735675720301935"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2020.03.051","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-dose adenosine for treatment of refractory paroxysmal supraventricular tachycardia","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2020.03.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}